The National Cyber Range (NCR) is an innovative Department of Defense (DoD) resource originally established by the Defense Advanced Research Projects Agency (DARPA) and now under the purview of the Test Resource Management Center (TRMC). It provides a unique environment for cybersecurity testing throughout the program development life cycle using unique methods to assess resiliency to advanced cyberspace security threats. This paper describes what a cybersecurity range is, how it might be employed, and the advantages a program manager (PM) can gain in applying the results of range events. Creating realism in a test environment isolated from the operational environment is a special challenge in cyberspace. Representing the scale and diversity of the complex DoD communications networks at a fidelity detailed enough to realistically portray current and anticipated attack strategies (e.g., malware, distributed denial of service attacks, cross-site scripting) is complex. The NCR addresses this challenge by representing an Internet-like environment by employing a multitude of virtual machines and physical hardware augmented with traffic emulation, port/protocol/service vulnerability scanning, and data capture tools. Coupled with a structured test methodology, the PM can efficiently and effectively engage with the Range to gain cyberspace resiliency insights. The NCR capability, when applied, allows the DoD to incorporate cybersecurity early to avoid highcost integration at the end of the development life cycle. This paper provides an overview of the resources of the NCR which may be especially helpful for DoD PMs to find the best approach for testing the cyberspace resiliency of their systems under development.

Background: Age-related declines in testosterone and growth hormone (GH) are associated with increased adiposity and decreases in lean mass and bone mineral density (BMD). A long-term retrospective study examined the effects of testosterone and/or GH supplementation on body composition and quality of life (QoL). Methods: A database survey assessed the records of 91 men and 97 women (ages 25-82) in treatment groups based on their hormonal status: dehydroepiandrosterone but no hormonal supplementation (control); testosterone only (Tes); GH only (GH); and testosterone plus GH (Tes+GH). Pre-and post-treatment assessments recorded changes in fat and lean mass, BMD, and QoL. Results: After an average of 3 years of treatment, weight decreased in women in the control and Tes+GH groups but remained stable in men in all groups. Tes and Tes+GH produced statistically signifi cant increases in lean mass, reductions in fat mass, and improvements in BMD in both sexes; GH produced similar changes in women. QoL and mood improved in all groups. Treatments were generally safe and well tolerated. Conclusions: In this retrospective survey, treatment with testosterone and/or GH was associated with favorable effects in men and women across a wide age range.